ArticleRheumatology (Oxford, England)2026
From paradox to biology: shared genetic architecture underlies the inverse association between smoking and Sjögren's disease.
Article in Rheumatology (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectivesSmoking has been consistently associated with a paradoxically lower risk of Sjögren's disease (SjD). We used genetic approaches to investigate whether this association reflects a causal effect of smoking or shared genetic architecture, and to identify shared loci that may help explain this paradox and inform disease biology.
methodsWe applied an integrated cross-trait genetic framework using genome-wide association data for smoking initiation and SjD. Conventional Mendelian randomization (MR) was used as an initial test of association, followed by genome-wide causal modelling (CAUSE and latent causal variable analysis) to distinguish directional causality from shared genetic architecture. Shared loci were identified using cross-trait pleiotropy analysis, refined through colocalization, and further explored using proteome-informed mediation analyses.
resultsConventional MR showed an inverse association between genetic liability to smoking initiation and SjD risk (OR 0.53, 95% CI 0.34-0.84). However, genome-wide modelling did not support a causal effect and instead suggested the association was driven by shared genetic influences. Cross-trait pleiotropy analysis identified 1536 variants across 11 loci, with colocalization supporting shared causal variants at five regions (3q13.32, 2q22.3, 8p21.2, 14q24.3 and 5q34). These loci implicated pathways related to neuroimmune signalling, epithelial organization and interferon regulation. Proteome-informed analyses identified no circulating proteins that robustly mediated the smoking-SjD relationship.
conclusionsThe inverse smoking-SjD association likely reflects shared genetic liability rather than a protective causal effect. These findings highlight biological pathways relevant to SjD pathogenesis and emphasize the importance of cautious interpretation of MR estimates when traits share genetic architecture.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.